rs116343381
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The NM_014956.5(CEP164):c.1639G>A(p.Glu547Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000532 in 1,614,130 control chromosomes in the GnomAD database, including 6 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. E547G) has been classified as Uncertain significance.
Frequency
Consequence
NM_014956.5 missense
Scores
Clinical Significance
Conservation
Publications
- ciliopathyInheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
- nephronophthisis 15Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), Laboratory for Molecular Medicine, Ambry Genetics, G2P
- Senior-Loken syndromeInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -20 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| CEP164 | NM_014956.5 | c.1639G>A | p.Glu547Lys | missense_variant | Exon 14 of 33 | ENST00000278935.8 | NP_055771.4 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| CEP164 | ENST00000278935.8 | c.1639G>A | p.Glu547Lys | missense_variant | Exon 14 of 33 | 1 | NM_014956.5 | ENSP00000278935.3 | ||
| CEP164 | ENST00000529153.5 | n.126G>A | non_coding_transcript_exon_variant | Exon 1 of 4 | 4 | |||||
| CEP164 | ENST00000533706.5 | n.963G>A | non_coding_transcript_exon_variant | Exon 7 of 27 | 5 | |||||
| CEP164 | ENST00000533675.5 | n.1832+989G>A | intron_variant | Intron 9 of 26 | 2 |
Frequencies
GnomAD3 genomes AF: 0.00286 AC: 435AN: 152214Hom.: 3 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.000668 AC: 168AN: 251316 AF XY: 0.000589 show subpopulations
GnomAD4 exome AF: 0.000289 AC: 423AN: 1461798Hom.: 3 Cov.: 30 AF XY: 0.000252 AC XY: 183AN XY: 727206 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.00286 AC: 435AN: 152332Hom.: 3 Cov.: 32 AF XY: 0.00285 AC XY: 212AN XY: 74484 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
not specified Benign:1
- -
CEP164-related disorder Benign:1
This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -
Nephronophthisis 15 Benign:1
- -
not provided Benign:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at